The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents
Abstract
DNA gyrase is classified as topoisomerase II, an ATP-dependent enzyme that is vital in the transcription, replication of DNA and chromosome segregation processes. It plays a crucial role in all bacteria except higher eukaryotes and this makes it a desirable and viable therapeutic target for development of new antibacterial agents. Fluoroquinolones are commonly used effective antibacterial agents that target DNA gyrase, however the spectrum of side-effects and emerging bacterial resistance with no new drugs in the antibacterial pipeline has fuelled intensive research in this area. New chemical entities with varied scaffolds possessing DNA gyrase inhibiting properties have been determined by screening chemical libraries that could serve as good leads for antibacterial drug development. A wide range of natural products and protein-based compounds have been identified and studied as DNA gyrase inhibitors and this adds a huge amount of structural diversity that can be exploited and harnessed in the discovery of new antibacterial agents. The development of new chemical compounds with DNA gyrase inhibitory activity (from natural sources, random screens or rational design) will further validate/corroborate the potential of this enzyme as a useful target. This review presents an overview of the DNA gyrase inhibitors obtained from natural and synthetic sources, their syntheses schemes and spectrum of biological activity of a variety of scaffolds and their analogues. The authors hope to provide focused direction for development of new chemical entities, synthetic routes for analogue synthesis, structure activity relationships and biological activity. The most potent ones can be used as templates to design novel compounds targeting DNA gyrase and are effective against resistant bacterial strains and biofilms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
DNA Topoisomerases: Structure, Function, and Mechanism
Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,743
Cellular roles of DNA topoisomerases: a molecular perspective
Wang, J. C. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm831 · Cited by 2,353
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Wang, J. C. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.003223 · Cited by 1,832
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents
Lesher, G. Y., Froelich, E. J., Gruett, M. D., Bailey, J. H., & Brundage, R. P. (1962) · Journal of Medicinal and Pharmaceutical Chemistry · doi:10.1021/jm01240a021 · Cited by 766
GHKL, an emergent ATPase/kinase superfamily
DUTTA, R., & INOUYE, M. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01503-0 · Cited by 762
Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
Gellert, M., O'Dea, M. H., Itoh, T., & Tomizawa, J. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.12.4474 · Cited by 727
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
Collin, F., Karkare, S., & Maxwell, A. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3557-z · Cited by 606
New topoisomerase essential for chromosome segregation in E. coli
Kato, J.-I., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S., & Suzuki, H. (1990) · Cell · doi:10.1016/0092-8674(90)90172-b · Cited by 566
The quinolones: decades of development and use
Emmerson, A. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg208 · Cited by 531
Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes
Bernard, P., & Couturier, M. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90629-x · Cited by 510
Tumor Cell Death Induced by Topoisomerase-Targeting Drugs
Li, T.-K., & Liu, L. F. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.53 · Cited by 508
Andersson, M. I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg212 · Cited by 503
DNA topoisomerases: harnessing and constraining energy to govern chromosome topology
Schoeffler, A. J., & Berger, J. M. (2008) · Quarterly Reviews of Biophysics · doi:10.1017/s003358350800468x · Cited by 490
Crystal structure of the breakage–reunion domain of DNA gyrase
Cabral, J. H. M., Jackson, A. P., Smith, C. V., Shikotra, N., Maxwell, A., & Liddington, R. C. (1997) · Nature · doi:10.1038/42294 · Cited by 456
Structure, Molecular Mechanisms, and Evolutionary Relationships in DNA Topoisomerases
Corbett, K. D., & Berger, J. M. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140357 · Cited by 426
DNA topoisomerase I is involved in both repression and activation of transcription
Merino, A., Madden, K. R., Lane, W. S., Champoux, J. J., & Reinberg, D. (1993) · Nature · doi:10.1038/365227a0 · Cited by 385
Lewis, R. J., Singh, O. M., Smith, C. V., Skarzynski, T., Maxwell, A., Wonacott, A. J., & Wigley, D. B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00483.x · Cited by 335
Fluoroquinolones: Action and Resistance
Drlica, K., & Malik, M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452537 · Cited by 317
Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase
Tran, J. H., Jacoby, G. A., & Hooper, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.118-125.2005 · Cited by 283
The ATP-Binding Site of Type II Topoisomerases as a Target for Antibacterial Drugs
Maxwell, A., & Lawson, D. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452500 · Cited by 277
Peng, H., & Marians, K. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80551-1 · Cited by 261
Green Tea Catechins Inhibit Bacterial DNA Gyrase by Interaction with Its ATP Binding Site
Gradišar, H., Pristovšek, P., Plaper, A., & Jerala, R. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm060817o · Cited by 241
Vetting, M. W., Hegde, S. S., Fajardo, J. E., Fiser, A., Roderick, S. L., Takiff, H. E., & Blanchard, J. S. (2006) · Biochemistry · doi:10.1021/bi052130w · Cited by 190
Structure-Based Discovery of Substituted 4,5′-Bithiazoles as Novel DNA Gyrase Inhibitors
Brvar, M., Perdih, A., Renko, M., Anderluh, G., Turk, D., & Solmajer, T. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300395d · Cited by 182
Bisacchi, G. S., & Manchester, J. I. (2015) · ACS Infectious Diseases · doi:10.1021/id500013t · Cited by 180
Bellon, S., Parsons, J. D., Wei, Y., Hayakawa, K., Swenson, L. L., Charifson, P. S., Lippke, J. A., Aldape, R., & Gross, C. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1856-1864.2004 · Cited by 159
Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor.
Yorgey, P., Lee, J., Kördel, J., Vivas, E., Warner, P. M., Jebaratnam, D. J., & Kolter, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4519 · Cited by 155
Quinolone-Binding Pocket of DNA Gyrase: Role of GyrB
Heddle, J. G., & Maxwell, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1805-1815.2002 · Cited by 125
Control of segregation of chromosomal DNA by sex factor F in Escherichia coli
Miki, T., Park, J. A., Nagao, K., Murayama, N., & Horiuchi, T. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)91024-j · Cited by 123
A Crystal Structure of the Bifunctional Antibiotic Simocyclinone D8, Bound to DNA Gyrase
Edwards, M. J., Flatman, R. H., Mitchenall, L. A., Stevenson, C. E. M., Le, T. B. K., Clarke, T. A., McKay, A. R., Fiedler, H., Buttner, M. J., Lawson, D. M., et al. (2009) · Science · doi:10.1126/science.1179123 · Cited by 90
Critchlow, S. E., O'Dea, M. H., Howells, A. J., Couturier, M., Gellert, M. F., & Maxwell, A. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1357 · Cited by 88
Schimana, J., Fiedler, H., Groth, I., SUBMUTH, R., Beil, W., Walker, M., & Zeeck, A. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.779 · Cited by 80
Microcin B17 Blocks DNA Replication and Induces the SOS System in Escherichia coli
Herrero, M., & Moreno, F. (1986) · Microbiology · doi:10.1099/00221287-132-2-393 · Cited by 80
Basarab, G. S., Doig, P. C., Galullo, V., Kern, G., Kimzey, A. L., Kutschke, A., Newman, J. P., Morningstar, M., Mueller, J. P., Otterson, L. G., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00863 · Cited by 78
Vibrio cholerae ParE2 Poisons DNA Gyrase via a Mechanism Distinct from Other Gyrase Inhibitors
Yuan, J., Sterckx, Y. G. ‐., Mitchenall, L. A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.138776 · Cited by 74
Mammalian topoisomerase I has base mismatch nicking activity.
Yeh, Y. C., Liu, H. F., Ellis, C. A., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40707-1 · Cited by 67
Haloemodin as Novel Antibacterial Agent Inhibiting DNA Gyrase and Bacterial Topoisomerase I
Duan, F., Li, X., Cai, S., Xin, G., Wang, Y., Du, D., He, S., Huang, B., Guo, X., Zhao, H., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401685f · Cited by 61
Patel, K., Tyagi, C., Goyal, S., Jamal, S., Wahi, D., Jain, R., Bharadvaja, N., & Grover, A. (2015) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2015.09.006 · Cited by 50
Self-citationHegde, S. S., Vetting, M. W., Mitchenall, L. A., Maxwell, A., & Blanchard, J. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01158-10 · Cited by 50
The genus Actinoallomurus and some of its metabolites
Pozzi, R., Simone, M., Mazzetti, C., Maffioli, S. I., Monciardini, P., Cavaletti, L., Bamonte, R., Sosio, M., & Donadio, S. (2010) · The Journal of Antibiotics · doi:10.1038/ja.2010.149 · Cited by 45
Microbial growth and production kinetics of Streptomyces antibioticus Tü 6040
Theobald, U., Schimana, J., & Fiedler, H. (2000) · Antonie van Leeuwenhoek · doi:10.1023/a:1010282818272 · Cited by 39
Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors
Chandran, M., Renuka, J., Sridevi, J. P., Pedgaonkar, G. S., Asmitha, V., Yogeeswari, P., & Sriram, D. (2015) · International Journal of Mycobacteriology · doi:10.1016/j.ijmyco.2015.02.002 · Cited by 31
N-Benzyl-3-sulfonamidopyrrolidines as novel inhibitors of cell division in E. coli
Mukherjee, S., Robinson, C. A., Howe, A. G., Mazor, T., Wood, P. A., Urgaonkar, S., Hebert, A. M., RayChaudhuri, D., & Shaw, J. T. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.010 · Cited by 28
New 1,4-dihydro[1,8]naphthyridine derivatives as DNA gyrase inhibitors
Karaca, H., Levent, S., Çevik, U. A., Özkay, Y., & Ilgın, S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.01.073 · Cited by 27
Alt, S., Burkard, N., Kulik, A., Grond, S., & Heide, L. E. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.12.016 · Cited by 26
A monoclonal antibody that inhibits mycobacterial DNA gyrase by a novel mechanism
Manjunatha, U. H. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki622 · Cited by 18
Edwards, M. J., Williams, M. A., Maxwell, A., & McKay, A. R. (2011) · Biochemistry · doi:10.1021/bi101691k · Cited by 17
Cited by
An overview of the use of nanozymes in antibacterial applications
Mei, L., Zhu, S., Liu, Y., Yin, W., Gu, Z., & Zhao, Y. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.129431 · Cited by 369
Mapping functional regions of essential bacterial proteins with dominant-negative protein fragments
Savinov, A., Fernandez, A., & Fields, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2200124119 · Cited by 8
Metadata
- Authors
- Khan, T., Sankhe, K., Suvarna, V., Sherje, A., Patel, K., & Dravyakar, B.
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 103
- Pages
- 923-938
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W2799775155
- Cited by
- 253
- References
- 50
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.